SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns record quarter and stronger-than-expected outlook, supported by AI-driven memory demand and tight supply, are driving attention. Traders are debating why the stock barely moved despite the resultssome say expectations were already priced in, while others remain bullish on demand; many also note that the flat reaction hurt earnings-option buyers.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is drawing attention as a selloff in long-duration Treasuries accompanies multi-decade highs in long-term yields, which persisted despite cooler-than-expected PCE data and reduced expectations for a Fed rate hike. Traders debate whether debt, inflation and bond-supply concerns will keep yields elevated or whether oversold conditions make bonds attractive, with some buying and many remaining bearish.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nikes upcoming fiscal first-quarter earnings report is the dominant focus, with traders debating whether results and guidance can signal a turnaround or deepen concerns about weak demand, competition, and execution. Bearish positioning is prominent as shares hover near multiyear lows, while some bulls see the crowded short trade as potential fuel for a relief rally.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles shipment of BlueBirds 1416 toward Cape Canaveral and its CEOs FCC discussions on direct-to-device spectrum are drawing attention; traders welcome the operational and regulatory progress but question its significance without a firm launch date or clearer launch cadence. A separate change-of-control severance policy has fueled takeover speculation, though no deal has been confirmed.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

A sharp move toward the $0.003 level has sparked breakout and altcoin-season speculation, with bullish traders pointing to Zebecs payroll and payments partnerships. Others argue the token has struggled to sustain gains and want stronger evidence of real product adoption and token demand.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

A prolonged selloff and weak price action are driving attention, with traders citing rising Treasury yields and rate-hike concerns as pressure on financial stocks. Many also blame prior share offerings and criticize management, while bulls argue SoFis growth remains intact and point to elevated short interest as a possible squeeze setup.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware judge ruled that Liquidias Yutrepia infringes two valid United Therapeutics patent claims covering PH-ILD treatment, prompting a sharp selloff as UTHR seeks an injunction and the court weighs remedies. Traders are debating whether the ruling could restrict Yutrepia sales or remove its PH-ILD indication versus being an overreaction, with Liquidia expected to appeal and the outcome still uncertain.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention after a high-volume breakout, with traders debating whether momentum and elevated short interest could fuel further gains or whether the move lacks a clear near-term announcement. Optimism also centers on Anktivas potential label expansion and international growth, while speculation about imminent positive news remains unconfirmed.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull shares are drawing attention after a steep pullback, with traders pointing to executive share sales as a possible source of selling pressure; others note the sales were pre-scheduled and blame shorting or weak sentiment. The debate contrasts persistent price weakness with bullish views that company growth and earnings remain strong, with some looking to the next report for a catalyst.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

The Pentagons planned Autonomous Warfare Command and broader push to expand autonomous drone capabilities have drawn attention to UMAC alongside other drone stocks. Traders view the initiative as a potential tailwind for domestic component suppliers, while some caution that specific contracts or funding for UMAC remain unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +6.41% and +15.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Upstream Bio, Inc. (UPB) Upgraded to Buy: What Does It Mean for the Stock?

Upstream Bio, Inc. (UPB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage...

Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +5.96% and +102.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Alnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue Estimates

Alnylam (ALNY) delivered earnings and revenue surprises of +39.00% and +2.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Upstream Bio (UPB) to Release Quarterly Earnings on Tuesday

Upstream Bio (NASDAQ:UPB) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

Upstream Bio, Inc. (NASDAQ:UPB) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) has been given an average rating of "Moderate Buy" by the five analysts that are covering the company, MarketBeat.com reports. One research analyst...

Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, two h...

Upstream Bio (NASDAQ:UPB) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered shares of Upstream Bio from a "hold" rating to a "sell" rating in a research note on Saturday...

Upstream Bio (NASDAQ:UPB) Downgraded by Evercore to In-Line

Evercore downgraded shares of Upstream Bio from an "outperform" rating to an "in-line" rating and set a $15.00 target price on the stock. in a research note on Friday...

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Upstream Bio Inc.

Why Did UPB Stock Plunge 40% Today?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$UPB 
 Verekitug’s efficacy for reducing asthma exacerbations appears comparable to Tezspire’s,  However, Verekitug can be administered less frequently.  Both therapeutics demonstrated a low incidence of serious TEAEs.

Trainguy1

$UPB Consistent with previous findings however Tezspire (tezepelumab) from AstraZeneca and Amgen significantly reduces the annualized asthma exacerbation rate by 56% to 71%. So Verekitug is second best

K Kum

$UPB I’m simultaneously upset I have funds tied up here with it going nowhere lately, yet reluctant to sell because I’m still optimistic…

Jarvis Cocker

$UPB I got a little let’s see how the phase updates go, i mean someone bought 102k shares at 6.01 so why not.

Megabyte

$UPB no bounce from the 52 week low and no buying pressure. This thing is going all the way down

Feed

News

Sentiment

Earnings

Fundamentals

Info

UPB Upstream Bio Inc.

Fundamentals

Latest UPB News